AMG:ETR
Amgen Inc
280,40 €
arrow_downward
-0,39%(-1,10) 1D
2 qer, 5:35:42 m.d., GMT+2 · EUR
search
Të gjitha simbolet
1D
5D
1M
6M
YTD
1V
5V
Maks
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për AMG...
Hap
281,80 €
I lartë
282,55 €
I ulët
278,70 €
Kapitalizimi i tregut
177,17Â mld
Vëllimi mesatar
364,00
Vëllimi
290,00
Maksimumi 52-javor
333,00 €
Minimumi 52-javor
230,00 €
Numri i punonjësve
32 mijë
Hap
281,80 €
I lartë
282,55 €
I ulët
278,70 €
Kapitalizimi i tregut
177,17Â mld
Vëllimi mesatar
364,00
Vëllimi
290,00
Maksimumi 52-javor
333,00 €
Minimumi 52-javor
230,00 €
Numri i punonjësve
32 mijë
Lajmet
Nga burimet nëpër ueb
Ad Hoc News
·
2 orë më parë
Amgen Inc. stock (US0311621009): EU approves Imdylltra as shares ease from recent highs
Traders Union
·
1 ditë më parë
Amgen shares dip amid rising selling pressure
MarketBeat
·
1 ditë më parë
Peapack Gladstone Financial Corp Sells 8,887 Shares of Amgen Inc. $AMGN
Yahoo Finance
·
1 ditë më parë
How The Amgen (AMGN) Story Is Evolving As Rare Disease Upside Meets Valuation Caution
Profili
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Rreth Amgen Inc
Drejtori ekzekutivRobert A. Bradway
Punonjësit31,5 mijë
Themeluar më8 pri 1980
SeliaThousand Oaks, Kalifornia, Shtetet e Bashkuara të Amerikës
Sektori-
Uebsajtiamgen.com
Përmbajtjet me IA mund të përfshijnë gabime. Mëso më shumë